The present invention encompasses a cancer vaccine therapy targeting Aspartyl-[Asparaginyl]-13- hydroxylase (HAAH). The present invention contemplates bacteriophage expressing HAAH peptide fragments and said bacteriophage for use in methods of treating cancer.
展开▼